Difficulty: Medium
Average Score: 63%
Practice
Preferential beta1 adrenergic blocking agent is
Correct answer
B
Rationale
In this question, the correct answer is B) Atenolol. Atenolol is a selective beta1 adrenergic blocking agent, meaning it primarily targets beta1 receptors in the heart. This selectivity makes it a preferential choice for conditions where blocking beta1 receptors is desired without affecting beta2 receptors found in the lungs.
Propranolol (Option A) is a non-selective beta blocker, affecting both beta1 and beta2 receptors. This can lead to unwanted side effects such as bronchoconstriction in patients with asthma or chronic obstructive pulmonary disease.
Penbutolol (Option C) and Oxprenolol (Option D) are non-selective beta blockers similar to Propranolol, so they do not fit the criteria of preferential beta1 adrenergic blocking agents.
Educationally, understanding the selectivity of beta blockers is crucial in clinical practice to choose the most appropriate medication for specific patient conditions. It also highlights the importance of drug specificity in achieving desired therapeutic effects while minimizing adverse reactions, showcasing the significance of pharmacological knowledge in healthcare decision-making.
Propranolol (Option A) is a non-selective beta blocker, affecting both beta1 and beta2 receptors. This can lead to unwanted side effects such as bronchoconstriction in patients with asthma or chronic obstructive pulmonary disease.
Penbutolol (Option C) and Oxprenolol (Option D) are non-selective beta blockers similar to Propranolol, so they do not fit the criteria of preferential beta1 adrenergic blocking agents.
Educationally, understanding the selectivity of beta blockers is crucial in clinical practice to choose the most appropriate medication for specific patient conditions. It also highlights the importance of drug specificity in achieving desired therapeutic effects while minimizing adverse reactions, showcasing the significance of pharmacological knowledge in healthcare decision-making.